New "guidelines" for treating pain due to diabetic peripheral neuropathy
New "guidelines" for treating pain due to diabetic peripheral neuropathy are getting lots of press.
Clinicians usually expect guidelines to come from long-established professional or governmental organizations.
These latest recommendations are from an advisory group of a relatively new organization, the American Society of Pain Educators.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote